Tecfidera Sales Data
|Rank 32||Current sales rank, all
Last updated: February 2014 (updated quarterly).
The following data shows Tecfidera U.S. retail sales in Q4 2013 compared to previous quarters.
|Date Range||Sales Rank||Sales ($000)||Units (000)|
|Q4 2013||32 (5)||$391,404||20.28%||113||16.49%|
|Q3 2013||37 ()||$325,424||97|
* Units refer to the number of packages sold.
|October 4, 2013||Tecfidera Offers a Wide Range of Benefits in MS|
|March 28, 2013||Tecfidera Approved for Multiple Sclerosis|
|March 20, 2013||US Patent Office Grants Patent Claiming Dosing Regimen for TECFIDERA (Dimethyl Fumarate)|